ReviewSkeletal radiology2015
Gemcitabine-induced radiation recall myositis.
Review in Skeletal radiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 28 citations in OpenAlex.
- Breast cancer radiotherapy in patients with autoimmune or cancer-associated myositis: balancing oncological benefit and immune-mediated risk.Radiation oncology (London, England) · 2026Review
- Radiation Recall Phenomenon Following Vaccination in a Patient With Prior Radiation to Lower Extremity Liposarcoma.Cureus · 2025Article
- Article
- Paraspinal radiation recall myositis after gemcitabine for pancreatic adenocarcinoma.BMJ case reports · 2021Review
- Pectoralis major radiation recall.Journal of medical radiation sciences · 2019Article
- Myositis following spine radiosurgery for metastatic disease: a case series.Journal of neurosurgery. Spine · 2018Article
- Radiologic Findings in Gabapentin-Induced Myositis.Journal of radiology case reports · 2017Article
- Neuropathies associated with lymphomaNeuro-oncology practice · 2015Review
- microRNA-218 promotes gemcitabine sensitivity in human pancreatic cancer cells by regulating HMGB1 expression.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2015Article
- Gemcitabine-Induced Radiation Recall Myositis: Case Report and Review of the Literature.Case reports in oncologyArticle
- Gemcitabine-induced radiation recall myositis in a patient with relapsed nasopharyngeal carcinoma.Practical radiation oncologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Radiation recall is an uncommon phenomenon in which administration of a chemotherapeutic agent induces an acute inflammatory reaction in previously irradiated tissues, often weeks to years after completion of radiotherapy. This entity is well known to medical and radiation oncologists, however only three cases have been reported in radiology journals. We present a case of gemcitabine-induced radiation recall that manifested as myositis with associated dermatitis in the posterior thigh of a patient with remote history of localized radiotherapy for biopsy-proven breast cancer metastasis. We also present a brief literature review to update the topic of radiation recall in imaging, and emphasize the importance of knowledge of this phenomenon when considering the differential diagnosis of myositis/dermatitis in a patient who has received cancer treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.